Prof. Lin Xie 谢琳
Chief Physician, Professor
Department of Digestive Oncology, Yunnan Cancer Hospital, Kunming
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of digestive system tumors.
Dr. Lin Xie is a Chief Physician, Professor, and doctoral supervisor at Yunnan Cancer Hospital. Dr. Xie is a visiting scholar at the Emory University Medical Oncology Center and holds titles including Yunnan Province Medical Discipline Leader and Academic and Technical Leader.
Name order: in Chinese the family name comes first (Xie Lin). Papers usually list the name as Lin Xie or Xie L.
Selected publications
36 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Int Med Res, 2026 (senior author): Risk stratification in colorectal cancer: A retrospective cohort study of nomograms based on inflammatory and immunohematological biomarkers. PubMed 42297383
- Front Immunol, 2025 (senior author): Circular RNA hsa_Circ_0007552 inhibits lung adenocarcinoma proliferation, migration and invasion via the miR-7974/BAP1 axis. PubMed 40918144
- J Immunol Res, 2025 (senior author): Exploring the Role of Cellular Interactions in the Colorectal Cancer Microenvironment. PubMed 40255905
- Front Oncol, 2024 (senior author): Long-term survival was achieved through multidisciplinary treatment of a patient with gallbladder carcinosarcoma accompanied by KRAS mutation: a case report and literature review. PubMed 40231011
- Sci Rep, 2024 (senior author): Evaluation of peripheral blood inflammation indexes as prognostic markers for colorectal cancer metastasis. PubMed 39227608
- Front Pharmacol, 2023 (senior author): Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches. PubMed 37927605
- Am J Transl Res, 2023 (senior author): LncRNA TEX41 regulates autophagy by increasing Runx2 expression in lung adenocarcinoma bone metastasis. PubMed 36915748
- Am J Transl Res, 2023 (senior author): ISG15 is a potential therapeutic target for osteosarcoma: a comprehensive analysis based on bioinformatics and in vitro experiments. PubMed 36915723
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion